News
Jacob Kimmel, president of NewLimit, says the last decade’s innovative progress has shown that humans have the ability to ...
Coinbase CEO Brian Armstrong believes this situation can be reversed, and says a health startup he cofounded is making faster ...
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors ...
NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many years to show progress toward this goal." ...
Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a $130 million series B fundraising round. The round was led by Kleiner Perkins ...
Others say it could even be reversible. Blake Byers, cofounder of biotech research company NewLimit, is taking it a step further. “Once thought to be irreversible, the emerging science of ...
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat ...
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results